Zu-chun Luo

Latest

• Risk of Adverse Drug Events Observed with Baricitinib 2mg Versus Baricitinib 4mg Once Daily for the Treatment of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials